C9 being a tetrasubstituted aza-quaternary stereocenter
(Scheme 1).
cyclindricine core; Zhang’s synthesis does not incorporate
the 5-alkyl side chain. We saw asymmetric Rh(I) catalyzed
[2 þ 2 þ 2] cycloadditions asa complementary approach to
the aza-Michael synthesis of the tricyclic cylindricine core
because it easily accesses a variety of analogs.
Scheme 1. Rh(I) Catalyzed Cycloadditions of 1,1-Disubstituted
Alkenyl Isocyanates and Alkynes, and Select Natural Products
Accessible from the Alkyl-Substituted Vinylogous Amide
Scaffold
Crucial to the development of an efficient route to the
cylindricine molecules was the design of a perfluorinated
Taddol phosphoramidite, CKphos,14 that overrides sub-
strate based control of product selectivity in the [2 þ 2 þ 2]
cycloaddition. This discovery allows for the highly selec-
tive formation of vinylogous amide indolizidinones with a
wide range of alkynes, including alkyl alkynes. Herein, we
report that Rh(I)•CKphos catalyzed cycloadditions are a
highly enantioselective method to form tetrasubstituted
N-stereocenters from 1,1-disubstitutedalkenyl isocyanates
and alkyl alkynes. Furthermore, Rh(I)•CKphos was used
to synthesize the tricyclic cylindricine core in 7 steps,
95% ee, and 11% overall yield.
Table 1. Ligand Screen for Rh(I) Catalyzed Cycloadditions of
1,1-Disubstituted Alkenyl Isocyanates and Alkynes
Due to their interesting architecture and biological
activity many methods to synthesize these tricyclic alka-
loids have been developed. Most of these syntheses are
racemic10 or use chiral starting materials11 and take ad-
vantage of an aza-Michael addition (single or double)
to form the functionalized piperidine core. Shibasaki12
(5 steps, 82% ee) and Zhang13 (10 steps, 87% ee) have
reported catalytic asymmetric approaches to the cylindri-
cines. While Shibasaki’s approach is very efficient, it uses
the traditional aza-Michael addition to synthesize the
a Reaction conditions: 1, 2 (1.3 equiv), [Rh(C2H4)2Cl]2 (2.5 mol %),
L (5 mol %) in PhMe at 110 °C for 16 h. b The combined isolated yield is
reported. c The enantiomeric excess shown is of the major product.
(10) (a) Snider, B. B.; Liu, T. J. Org. Chem. 1997, 62, 5630–5633. (b)
Liu, J. F.; Heathcock, C. H. J. Org. Chem. 1999, 64, 8263–8266. (c) Flick,
A. C.; Caballero, M. J. A.; Padwa, A. Org. Lett. 2008, 10, 1871–1874. (d)
Vital, P.; Hosseini, M.; Shanmugham, M. S.; Gotfredsen, C. H.; Harris,
P.; Tanner, D. Chem. Commun. 2009, 1888–1890. (e) Donohoe, T. J.;
Brian, P. M.; Hargaden, G. C.; O’Riordan, T. J. C. Tetrahedron 2010, 66,
6411–6420. (f) Lapointe, G.; Schenk, K.; Renaud, P. Org. Lett. 2011, 13,
4774–4777.
Vinylogous amide formation with 1,1-disubstituted al-
kenes previously required aryl acetylenes because alkyl
alkynes produced a lactam cycloadduct (Table 1).4 A
screen of ligands revealed that this inherent substrate bias
of product selectivity could be altered by the phosphor-
amidite on rhodium. m-Xylyl Taddol phosphoramidite
T2 provides lactam 3 in 6.5:1 selectivity. Guiphos B1 and
t-BuBiaryl B2 modestly favor vinylogous amide, but in the
case of B2 the enantioselectivity is poor (27%). CKPhos
provides vinylogous amide 4 with excellent product
(1:>19) and enantioselectivity (90%) and good yield (61%).
We found that Rh(I)•CKphos provides a selective
means of forming vinylogous amides from alkyl alkynes
and 1,1-disubstituted alkenes (Figure 1). A variety of
€
(11) (a) Molander, G. A.; Ronn, M. J. Org. Chem. 1999, 64, 5183–
5187. (b) Trost, B. M.; Rudd, M. T. Org. Lett. 2003, 5, 4599–4602. (c)
Canesi, S.; Bouchu, D.; Ciufolini, M. A. Angew. Chem., Int. Ed. 2004, 43,
4336–4338. (d) Arai, T.; Abe, H.; Aoyagi, S.; Kibayashi, C. Tetrahedron
Lett. 2004, 45, 5921–5924. (e) Liu, J.; Hsung, R. P.; Peters, S. D. Org.
Lett. 2004, 6, 3989–3992. (f) Abe, H.; Aoyagi, S.; Kibayashi, C. J. Am.
Chem. Soc. 2005, 127, 1473–1480. (g) Liu, J.; Swidorski, J. J.; Peters,
S. D.; Hsung, R. P. J. Org. Chem. 2005, 70, 3898–3902. (h) Swidorski, J.;
Wang, J.; Hsung, R. P. Org. Lett. 2005, 8, 777–780. (i) Zou, J.; Cho,
D. W.; Mariano, P. S. Tetrahedron 2010, 66, 5955–5961. (j) Mei, S.-L.;
Zhao, G. Eur. J. Org. Chem. 2010, 1660–1668. (k) Hardin Narayan,
A. R.; Sarpong, R. Org. Biomol. Chem. 2012, 10, 70–78.
(12) Shibuguchi, T.; Mihara, H.; Kuramochi, A.; Sakuraba, S.;
Ohshima, T.; Shibasaki, M. Angew. Chem., Int. Ed. 2006, 45, 4635–4637.
(13) Zhang, X.-M.; Wang, M.; Tu, Y.-Q.; Fan, C.-A.; Jiang, Y.-J.;
Zhang, S.-Y.; Zhang, F.-M. Synlett 2008, 2831–2835.
ꢀ
(14) (a) Dalton, D. M.; Rappe, A. K.; Rovis, T. Chem. Sci. 2013, 4,
2062–2070. (b) Perreault, S.; Rovis, T. Synthesis 2013, 45, 719–728.
B
Org. Lett., Vol. XX, No. XX, XXXX